Rising number of surgical processes coupled with increasing trauma cases, increase in road accidents and need for reduction of blood loss coupled with rapid development and launch of innovative tissue sealing compounds are key factors contributing to high CAGR of Hemostasis and Tissue Sealing Agents during forecast period.
Market Size – USD 3.63 Billion in 2018, Market Growth - CAGR of 8.1%, Market Trends – Increase in the demand for advanced technology in healthcare sector and increased number of target diseases and surgeries
According to the current analysis of Reports and Data, the global Hemostasis and Tissue Sealing Agents market was valued at USD 3.63 billion in 2018 and is expected to reach USD 6.76 billion by the year 2026, at a CAGR of 8.1%. Blood loss has always been a concern in surgery. Hemostasis is the formation of blood clots at the site of injury. It is a complex interaction between the platelets plasma proteins and coagulation and fibrinolysis pathways. Platelets provide the initial hemostasis response.
The number of hemostatic agents and tissue sealants have been developed and are currently used in various surgical disciplines all across the world. Hemostasis and tissue sealing agents are used in medical applications and act as a catalyst in blood clotting. This reduces the time required for clotting of the blood and prevents blood loss. An increase in the adoption of advanced technologies and increasing investment in the healthcare infrastructure is expected to drive the market growth in the coming decades. Additionally, the increasing number of diabetic patients, cardiovascular conditions, urological issues, liver problems, and gastrointestinal conditions owing to the changed lifestyle and inappropriate eating habits among the population is expected to raise the number of surgeries. For instance, according to the CDC, these procedures categories made up 72% of procedures performed on females and 67% of those performed on males. It is anticipated to drive the market growth positively for hemostasis and tissue sealing products in the market during the forecast period.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2257
The report puts an emphasis on the information regarding the key players with a special focus on their company profile, business overview, recent advancements, product catalog, and strategic business plans. It provides a comprehensive overview of the strategic alliances in the market under taken by the key players such as mergers and acquisitions, joint ventures, collaborations, partnerships, agreements, product launches, brand promotions, and corporate deals, among others.
Key companies operating in the market and profiled in the report include:
Johnson Johnson, C R Bard, Integra Life Sciences, Cohera Medical, Equimedical, CryoLife, Advance Medical, Solution, Smith Nephew, Pfizer, and B Braun Medical Inc.
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/2257
The Hemostasis And Tissue Sealing Agents market takes into account major geographical locations such as North America, Europe, Asia Pacific, Latin America, and Middle East Africa to offer key insights into market growth, market size, market share, revenue growth, current and emerging trends, supply and demand ratio, import/export, consumer demand and behavior, and presence of key players in each region. The report offers an in-depth country wise analysis to impart better understanding of the market and its growth prospects.
Segments Covered in the report
Type (Revenue, USD Million; 2016–2026)
- Topical Hemostats
- Adhesives Tissue sealants
- Others
Material type (Revenue, USD Million; 2016–2026)
- Collagen Based
- Oxidized Regenerated Cellulose (ORC) based
- Gelatin based
- Polysaccharide Based
- Others
Applications Type (Revenue, USD Million; 2016–2026)
- Minimally invasive surgery
- General Surgery
- Others
End Use (Revenue, USD Million; 2016–2026)
- Hospital
- Ambulatory Surgical Centers
- Home Care Settings
- Others
Key Regions Analyzed in the Report include:
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- Italy
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Rest of MEA
To know more about the report @ https://www.reportsanddata.com/report-detail/hemostasis-and-tissue-sealing-agents-market
Furthermore, it consists information about individual segment of the Hemostasis And Tissue Sealing Agents market based on the types and application. The report also offers insights about the key segments expected to register significant revenue growth over the forecast period and primary trends influencing their growth. It also offers CAGR and market share values for each segment to provide clear understanding of demand and trend in the global market.
Further key findings from the report suggest
- Hemostasis and Tissue Sealing Agents market is growing at a CAGR of 9% in Asia Pacific followed by North America and Europe, with 8.1 % and 8.0 % CAGR, respectively. Increased demand of hemostats and tissue sealants in the surgical processes is driving the growth of the market.
- In 2018, Topical Hemostats segment is expected to dominate Hemostasis and Tissue Sealing Agents which holds 51.3% of the global market. North America regional market is the chief revenue generating source for this product segment, followed by European countries and Asia-Pacific regions
- Chronic diseases like Diabetes, Hernia fixation, urological disorders, spinal injuries, brain hemorrhage and liver injuries are few diseases that require the usage of hemostats and tissue sealing products. Increase in these diseases will ultimately lead to an increase in demand for tissue sealants. For instance, a new 'biological glue' developed by Chinese researchers could one day stop hearts and arteries from uncontrollably bleeding.
- Increased preference of hemostats and tissue sealants over the other products for the process of injury healing or wound closure has led to its increasing use in multiple conditions, especially in endoscopic procedures.
- Minimally invasive surgery is making use of hemostasis and tissue sealing products for urological treatments, thereby promoting the growth of Hemostasis and tissue sealing market. For instance, in June 2019, FDA clears JJ and Grifols' blood-stopping protein spray for surgical bleeds
- The highest demand is expected from the cardiovascular conditions followed by general surgeries. For instance, according to the data of National Center for Health Statistics, 48 million surgical inpatient procedures were performed in the United States
- Owing to the better results obtained by using hemostasis and tissue sealing products in cardiovascular surgeries and general surgeries has attributed to an increased demand for tissue sealing products.
- Topical hemostat is extensively used in general injury treatment and provides cost efficiency, quick and easy absorbability, minimal tissue reaction and non-antigenicity owing to the larger share of the market by topical hemostats segment.
- Hemostasis includes the coagulation of blood vessels, fibrinolysis and platelet aggregation pathways by activation of hemostasis system. Hemostats involve hemostasis agents and their delivering medium which could be ready-to-use applicator or a pre-filled syringe.
- Some of the prime advantages associated with tissue sealants are, ease of use, better visualization, reduced need for transfusion, better application in patients with coagulation disorders, reduced exudates and so on.
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2257
Thank you for reading our report. For any specific details on customization of this report, please get in touch with us. We will ensure the report you get is well-suited to your needs.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
